HYDERABAD, India--(BUSINESS WIRE)--Aug. 29, 2006--Lipicard Technologies’ PLATROL(R) is a novel antiplatelet drug with 40% higher efficacy and near-zero toxicity compared to Aspirin & Clopidogrel. The only other new antiplatelet drugs in the research pipeline are Nitric Oxide (NO) releasing Aspirin derivatives, which are clinically inferior to PLATROL(R).
